TIJANA NESKOVIC: Open Payments
NPI 1750123089 · MURPHY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $112 |
| Dexcom, Inc. | 4 | $95 |
| Novo Nordisk Inc | 3 | $63 |
| Lilly USA, LLC | 4 | $60 |
| Amgen Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Astellas Pharma US Inc | 2 | $34 |
| Tandem Diabetes Care, Inc. | 1 | $24 |
| Renalytix AI, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: NURTEC ODT, Dexcom G6 Transmitter, OTEZLA, BREZTRI, MOUNJARO, Wegovy, Veozah, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across TX — which companies pay providers there.
